A comparative trial of amoxycillin 3g bd and conventional amoxycillin therapy in the treatment of urinary tract infection in a general practice population.

Abstract	An open, randomised, General Practice study was carried out to determine the comparative efficacy and tolerability of two doses of amoxycillin 3 g and amoxycillin 250 mg tds for five days in the treatment of uncomplicated urinary tract infection. Two hundred and seven patients entered the study, of these 98 were shown to have negative bacteriology. Using pre- and post-treatment MSU culture and symptomatology as measures of efficacy it was found that the two treatment groups were not significantly different on both measures. Both treatments were well tolerated with only a low level of gastrointestinal side effects reported.
Authors	A M Abbas, P K Goel, A P Smaling, A Davey, R J Ancill
Journal	The Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 11 Issue 6 Pg. 593-6 (Jun 1983) ISSN: 0305-7453 [Print] England
PMID	6885683 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Amoxicillin
Topics	Amoxicillin (administration & dosage, adverse effects) Drug Administration Schedule Humans Urinary Tract Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!